Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis - Wikidata - awgldk - TriplyDB

Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis

Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis

http://www.wikidata.org/entity/Q58034394

about

Pleiotropic effects of statins in the diseases of the liver Thrombin activation and liver inflammation in advanced hepatitis C virus infection Laparoscopic Splenectomy and Azygoportal Disconnection: a Systematic Review Response to the NCEPOD report: development of a care bundle for patients admitted with decompensated cirrhosis—the first 24 h Hemostasis in liver transplantation: Pathophysiology, monitoring, and treatment Therapeutic and clinical aspects of portal vein thrombosis in patients with cirrhosis Coagulopathy in liver disease: Lack of an assessment tool Therapy Algorithm for Portal Vein Thrombosis in Liver Cirrhosis: The Internist's Point of View Review article: portal vein obstruction--epidemiology, pathogenesis, natural history, prognosis and treatment Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia Transitional Remodeling of the Hepatic Extracellular Matrix in Alcohol-Induced Liver Injury Differential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosis Anticoagulation in cirrhosis: a new paradigm?Advanced non-alcoholic steatohepatitis cirrhosis: A high-risk population for pre-liver transplant portal vein thrombosis.Changing Concepts of Cirrhotic Coagulopathy.Liver transplant recipients with portal vein thrombosis receiving an organ from a high-risk donor are at an increased risk for graft loss due to hepatic artery thrombosis.Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry.Direct Oral Anticoagulants in Cirrhosis.Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation.Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: A meta-analysis.Portal vein thrombosis: When to treat and how?Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis.Changing common sense: Anti-platelet/coagulation therapy against cirrhosis.Effects of restoring portal flow with anticoagulation and partial splenorenal shunt embolization.Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment.Spontaneous bleeding or thrombosis in cirrhosis: What should be feared the most?Cirrhosis and its complications: evidence based treatment.Deep vein thrombosis and pulmonary embolism in cirrhotic patients: systematic review.Portal vein thrombosis in patients with cirrhosis.Coagulation in liver toxicity and disease: role of hepatocyte tissue factor.Initial management of noncirrhotic splanchnic vein thrombosis: when is anticoagulation enough?Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis.Hepatic congestion leads to fibrosis: findings in a newly developed murine model.Association between Portal Vein Thrombosis and Survival in Non-Liver-Transplant Patients with Liver Cirrhosis: A Systematic Review of the Literature Coagulation-driven platelet activation reduces cholestatic liver injury and fibrosis in mice.Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen.Dual-sugar tests of small intestinal permeability are poor predictors of bacterial infections and mortality in cirrhosis: A prospective study.Differential Kinetics of Coagulation Factors and Natural Anticoagulants in Patients with Liver Cirrhosis: Potential Clinical Implications Autoimmune conditions are associated with perioperative thrombotic complications in liver transplant recipients: A UNOS database analysis.

P2860

Q26741176-A8FB5BBB-C9C7-4484-AF7D-EA32CA1203AA Q26749460-25C9D3C4-DACF-4FB1-A3A7-556F0E5C802D Q26768623-6F6C39BB-749B-499C-BBE0-D76B2DB8E49C Q26770382-1659FF54-6476-49D6-B670-CB28A1180D2B Q26773233-AD6E82A6-71C6-460E-A528-CBFBA4D7FDA3 Q26774531-2A5704BC-4ABA-4C71-A2E7-3F819DB735FC Q26781714-6EEB69B0-C4DD-434F-B89D-16F76454CDF0 Q26796507-B2415CE2-3B26-44EF-898C-C06AA8F4BCE7 Q26825552-F4207BED-B728-4A25-85E6-F416F2811B94 Q26826919-1A6FAB17-A92B-45C2-A04B-5C83311570D0 Q28071500-F3CDB89B-90CF-403B-B796-1BC2480D4E09 Q28539503-65ED3BF7-CACC-4CB9-BFFE-C1E9E5322E48 Q30235307-D4EB0E3F-AAD0-437A-98B3-B841D8A304E9 Q30274723-D3B18262-EF9B-4A5D-B960-88DCF113F140 Q30275544-116E77B6-B462-42BB-852B-FBEC2F4B30BC Q30275773-04F8F6FD-62B2-45E9-A5BA-E0CF66ABDE8C Q30277075-57D6AD93-3E63-46C5-80F2-0F840FCC8416 Q30277086-D8CB8E1B-CEAB-4472-8E4E-1F50BB2F1888 Q30277088-3E42DF33-69C8-4CE9-A39F-D40543A935D7 Q30277819-EB22AEBB-F37C-49F7-8AF9-9D8B8E66E562 Q30277946-0D6ACAF6-F863-4C72-A158-B3EDF59841A8 Q30278059-1322CB84-AC66-48B4-839E-E46293ADF86A Q30300233-0B307DAE-9604-4E07-BFF2-4E224AAC5480 Q30379953-06304B69-633F-4CC4-9437-2C6E3366FC86 Q30458237-8AD3D93F-4A25-4D21-9509-E96D357B898E Q33422300-EDA971A2-EC59-4DD8-9F8E-73E794220A47 Q33424708-205F4440-1EEC-4D4C-B4E8-FC0291506572 Q33594931-9AFBD15E-3509-4B46-98CD-588F402AD411 Q33626817-B3C85EE8-26B6-479B-8651-8EAD4F40C159 Q33647169-088A57F6-E485-4FEB-9830-ED77AD7EADA9 Q33664922-75F4DA92-2628-41C7-9139-C76B4F643AAE Q33810181-AA6DB02C-B11E-4EBF-A020-53810EC1AF25 Q34779767-49E63348-57BB-41D5-8D59-228674A99D4A Q35001914-86733E6F-0A78-4208-A68F-701A4301BD47 Q35587116-E2C88CF7-563C-4C3C-8825-ABD35F69FC66 Q35806023-70F7F062-76BE-4E72-AC6E-62A5F5A7EF5C Q35911484-0CB907FF-DB98-4211-9F80-3167E2D4DC71 Q35966499-D4C7F05A-C8EB-4507-9968-DF37FD17B7B4 Q36015509-57084B85-4B0C-484A-8BB7-59C1171BC6A1 Q36024830-C05CF813-61D6-4352-A8BA-CDA5DC6D6977

P2860

Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis

http://www.wikidata.org/entity/Q58034394

description

im November 2012 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 20 July 2012

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2012

@uk

name

Enoxaparin Prevents Portal Vei ...... tients With Advanced Cirrhosis

@en

Enoxaparin Prevents Portal Vei ...... tients With Advanced Cirrhosis

@nl

type

label

Enoxaparin Prevents Portal Vei ...... tients With Advanced Cirrhosis

@en

Enoxaparin Prevents Portal Vei ...... tients With Advanced Cirrhosis

@nl

prefLabel

Enoxaparin Prevents Portal Vei ...... tients With Advanced Cirrhosis

@en

Enoxaparin Prevents Portal Vei ...... tients With Advanced Cirrhosis

@nl

P1433

Q58034394-B524490E-1BE7-45FF-8466-2CE871F1094F

P1476

Q58034394-1DB86C7B-21C0-4926-BA1F-598B8523F878

P2093

Q58034394-04E84AA1-3752-4BC9-ABD3-9632FB240D9F

Q58034394-147C6138-87E9-45CD-A0FE-2DDC41B4B258

Q58034394-16810F89-37C5-44B3-AD83-A40C6FF5359C

Q58034394-1F346B5E-FDB0-4821-A745-B78E3853F69C

Q58034394-2E04E5BF-2DF8-431E-83F9-F22A7A4EE0A1

Q58034394-3A7E088A-D5B8-44F7-BEAB-1DCC1E614219

Q58034394-3CA66FD9-DC7E-453B-83FC-BDEEB2822D78

Q58034394-4753103F-D08B-43CF-B2E5-558113F53E0B

Q58034394-4A7B8197-4A9A-4BE7-B029-73273A80A0CE

Q58034394-79E45AD9-5111-49BE-ABE3-BF791EFAEF37

P304

Q58034394-D4F42A15-839F-4FEE-9CAE-6EE04F14454A

P31

Q58034394-3B173533-A61B-4ECD-92D0-F444D0BB0643

P356

Q58034394-3778855E-C9AD-4191-9730-0AD4578123DB

P407

Q58034394-79549361-0BA7-4617-AE9F-2C2976FD83DE

P433

Q58034394-F6EA33DB-4D19-4365-96ED-CD26A7A6A854

P478

Q58034394-C6524C3D-346D-4FB5-A228-C926724C1826

P50

Q58034394-108A634A-719A-4906-9729-26363820815E

Q58034394-1EC49B71-8148-4EBA-829B-6A92090068F8

Q58034394-5EC3413A-1E00-4F2E-92A3-076D553F5553

P577

Q58034394-E14A7FD4-6945-44B6-A013-7FF0B706CD21

P698

Q58034394-CAD0CE59-8F3E-4C04-A78F-E52A650CD50D

P921

Q58034394-2F7B515F-1F6E-41DD-93B2-664F5EC77584

Q58034394-72B306B8-E9AD-4FF5-A121-16292FACE906

Q58034394-C3A12EA9-1D89-4F1F-9B79-24FB3797765F

Q58034394-F50D9B70-49D0-4AF1-B265-9E0E0F6B480B

P356

J.GASTRO.2012.07.018

P1433

Gastroenterology

P1476

Enoxaparin prevents portal vei ...... tients with advanced cirrhosis

@en

P2093

Aimilia Karampatou

http://www.w3.org/2001/XMLSchema#string

Anna Ferrari

http://www.w3.org/2001/XMLSchema#string

Barbara Lei

http://www.w3.org/2001/XMLSchema#string

Beatrice Zambotto

http://www.w3.org/2001/XMLSchema#string

Calogero Cammà

http://www.w3.org/2001/XMLSchema#string

Cristian Caporali

http://www.w3.org/2001/XMLSchema#string

Cristina Tata

http://www.w3.org/2001/XMLSchema#string

Elena Turola

http://www.w3.org/2001/XMLSchema#string

Erica Villa

http://www.w3.org/2001/XMLSchema#string

Giovanni Fornaciari

http://www.w3.org/2001/XMLSchema#string

P304

1253-1260.e4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2012.07.018

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

143

http://www.w3.org/2001/XMLSchema#string

P50

Salvatore Petta

Dominique C Valla

Filippo Schepis

P577

2012-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22819864

http://www.w3.org/2001/XMLSchema#string

P921

gastroenterology

liver cirrhosis